nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosfomycin—Anorexia—Erlotinib—pancreatic cancer	0.00332	0.00332	CcSEcCtD
Fosfomycin—Phosphatase alkaline increased—Epirubicin—pancreatic cancer	0.00325	0.00325	CcSEcCtD
Fosfomycin—Vaginal inflammation—Epirubicin—pancreatic cancer	0.00325	0.00325	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00321	0.00321	CcSEcCtD
Fosfomycin—Insomnia—Tamoxifen—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Fosfomycin—Blood bilirubin increased—Doxorubicin—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Fosfomycin—Paraesthesia—Tamoxifen—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Fosfomycin—Insomnia—Erlotinib—pancreatic cancer	0.00315	0.00315	CcSEcCtD
Fosfomycin—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.00315	0.00315	CcSEcCtD
Fosfomycin—Myalgia—Sunitinib—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Fosfomycin—Dyspepsia—Tamoxifen—pancreatic cancer	0.0031	0.0031	CcSEcCtD
Fosfomycin—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Fosfomycin—Dry mouth—Sunitinib—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Fosfomycin—Dyspepsia—Erlotinib—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Fosfomycin—Vaginal infection—Epirubicin—pancreatic cancer	0.00306	0.00306	CcSEcCtD
Fosfomycin—Decreased appetite—Tamoxifen—pancreatic cancer	0.00306	0.00306	CcSEcCtD
Fosfomycin—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Fosfomycin—Decreased appetite—Erlotinib—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Fosfomycin—Pain—Tamoxifen—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Fosfomycin—Constipation—Tamoxifen—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Fosfomycin—Phosphatase alkaline increased—Doxorubicin—pancreatic cancer	0.003	0.003	CcSEcCtD
Fosfomycin—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.003	0.003	CcSEcCtD
Fosfomycin—Flatulence—Irinotecan—pancreatic cancer	0.003	0.003	CcSEcCtD
Fosfomycin—Infection—Sunitinib—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Fosfomycin—Pain—Erlotinib—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Fosfomycin—Constipation—Erlotinib—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Fosfomycin—Back pain—Irinotecan—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Fosfomycin—Skin disorder—Sunitinib—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Fosfomycin—Anorexia—Sunitinib—pancreatic cancer	0.00287	0.00287	CcSEcCtD
Fosfomycin—Back pain—Gemcitabine—pancreatic cancer	0.00287	0.00287	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Fosfomycin—Vaginal infection—Doxorubicin—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Fosfomycin—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Fosfomycin—Abdominal pain—Tamoxifen—pancreatic cancer	0.00278	0.00278	CcSEcCtD
Fosfomycin—Lymphadenopathy—Epirubicin—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Fosfomycin—Abdominal pain—Erlotinib—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Fosfomycin—Body temperature increased—Erlotinib—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Fosfomycin—Insomnia—Sunitinib—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Fosfomycin—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Fosfomycin—Paraesthesia—Sunitinib—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Fosfomycin—Dyspepsia—Sunitinib—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Fosfomycin—Decreased appetite—Sunitinib—pancreatic cancer	0.00262	0.00262	CcSEcCtD
Fosfomycin—Pain—Sunitinib—pancreatic cancer	0.00258	0.00258	CcSEcCtD
Fosfomycin—Constipation—Sunitinib—pancreatic cancer	0.00258	0.00258	CcSEcCtD
Fosfomycin—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.00255	0.00255	CcSEcCtD
Fosfomycin—Asthenia—Tamoxifen—pancreatic cancer	0.00253	0.00253	CcSEcCtD
Fosfomycin—Myalgia—Gemcitabine—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Fosfomycin—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.00251	0.00251	CcSEcCtD
Fosfomycin—Asthenia—Erlotinib—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Fosfomycin—Pruritus—Tamoxifen—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Fosfomycin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Fosfomycin—Myalgia—Fluorouracil—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Fosfomycin—Infection—Irinotecan—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Fosfomycin—Pruritus—Erlotinib—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Fosfomycin—Rhinitis—Docetaxel—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Fosfomycin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Fosfomycin—Diarrhoea—Tamoxifen—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Fosfomycin—Infection—Gemcitabine—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Fosfomycin—Pharyngitis—Docetaxel—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Fosfomycin—Abdominal pain—Sunitinib—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Fosfomycin—Body temperature increased—Sunitinib—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Fosfomycin—Diarrhoea—Erlotinib—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Fosfomycin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Fosfomycin—Anorexia—Irinotecan—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Fosfomycin—Infection—Fluorouracil—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Fosfomycin—Skin disorder—Gemcitabine—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Fosfomycin—Dizziness—Tamoxifen—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Fosfomycin—Migraine—Epirubicin—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Fosfomycin—Anorexia—Gemcitabine—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Fosfomycin—Dizziness—Erlotinib—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Fosfomycin—Anorexia—Fluorouracil—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Fosfomycin—Insomnia—Irinotecan—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Fosfomycin—Vomiting—Tamoxifen—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Fosfomycin—Paraesthesia—Irinotecan—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Fosfomycin—Rash—Tamoxifen—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Fosfomycin—Dermatitis—Tamoxifen—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Fosfomycin—Vomiting—Erlotinib—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Fosfomycin—Somnolence—Irinotecan—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Fosfomycin—Headache—Tamoxifen—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Fosfomycin—Rash—Erlotinib—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Fosfomycin—Dermatitis—Erlotinib—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Fosfomycin—Insomnia—Gemcitabine—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Fosfomycin—Dyspepsia—Irinotecan—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Fosfomycin—Headache—Erlotinib—pancreatic cancer	0.00218	0.00218	CcSEcCtD
Fosfomycin—Paraesthesia—Gemcitabine—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Fosfomycin—Asthenia—Sunitinib—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Fosfomycin—Decreased appetite—Irinotecan—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Fosfomycin—Insomnia—Fluorouracil—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Fosfomycin—Somnolence—Gemcitabine—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Fosfomycin—Migraine—Doxorubicin—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Fosfomycin—Paraesthesia—Fluorouracil—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Fosfomycin—Pruritus—Sunitinib—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Fosfomycin—Pain—Irinotecan—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Fosfomycin—Constipation—Irinotecan—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Fosfomycin—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Fosfomycin—Somnolence—Fluorouracil—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Fosfomycin—Decreased appetite—Gemcitabine—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Fosfomycin—Dyspepsia—Fluorouracil—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Fosfomycin—Nausea—Tamoxifen—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Fosfomycin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Fosfomycin—Constipation—Gemcitabine—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Fosfomycin—Pain—Gemcitabine—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Fosfomycin—Nausea—Erlotinib—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Fosfomycin—Decreased appetite—Fluorouracil—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Fosfomycin—Diarrhoea—Sunitinib—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Fosfomycin—Asthma—Epirubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Fosfomycin—Influenza—Epirubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Fosfomycin—Back pain—Docetaxel—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Fosfomycin—Pain—Fluorouracil—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Fosfomycin—Eosinophilia—Epirubicin—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Fosfomycin—Dizziness—Sunitinib—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Fosfomycin—Abdominal pain—Irinotecan—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Fosfomycin—Body temperature increased—Irinotecan—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Fosfomycin—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Fosfomycin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Fosfomycin—Vomiting—Sunitinib—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Fosfomycin—Body temperature increased—Gemcitabine—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Fosfomycin—Dysuria—Epirubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Fosfomycin—Rash—Sunitinib—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Fosfomycin—Dermatitis—Sunitinib—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Fosfomycin—Headache—Sunitinib—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Fosfomycin—Influenza—Doxorubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Fosfomycin—Asthma—Doxorubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Fosfomycin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Fosfomycin—Eosinophilia—Doxorubicin—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Fosfomycin—Myalgia—Docetaxel—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Fosfomycin—Nausea—Sunitinib—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Fosfomycin—Asthenia—Irinotecan—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Fosfomycin—Dysuria—Doxorubicin—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Fosfomycin—Dry mouth—Docetaxel—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Fosfomycin—Asthenia—Gemcitabine—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Fosfomycin—Haematuria—Epirubicin—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Fosfomycin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Fosfomycin—Pruritus—Gemcitabine—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Fosfomycin—Infection—Docetaxel—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Fosfomycin—Diarrhoea—Irinotecan—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Fosfomycin—Pruritus—Fluorouracil—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Fosfomycin—Skin disorder—Docetaxel—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Fosfomycin—Diarrhoea—Gemcitabine—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Fosfomycin—Dizziness—Irinotecan—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Fosfomycin—Anorexia—Docetaxel—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Fosfomycin—Rhinitis—Epirubicin—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Fosfomycin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Fosfomycin—Pharyngitis—Epirubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Fosfomycin—Haematuria—Doxorubicin—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Fosfomycin—Vomiting—Irinotecan—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Fosfomycin—Dizziness—Fluorouracil—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Fosfomycin—Rash—Irinotecan—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Fosfomycin—Dermatitis—Irinotecan—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Fosfomycin—Headache—Irinotecan—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Fosfomycin—Insomnia—Docetaxel—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Fosfomycin—Paraesthesia—Docetaxel—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Fosfomycin—Vomiting—Gemcitabine—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Fosfomycin—Somnolence—Docetaxel—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Fosfomycin—Rash—Gemcitabine—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Fosfomycin—Dermatitis—Gemcitabine—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Fosfomycin—Headache—Gemcitabine—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Fosfomycin—Vomiting—Fluorouracil—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Fosfomycin—Rhinitis—Doxorubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Fosfomycin—Dyspepsia—Docetaxel—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Fosfomycin—Rash—Fluorouracil—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Fosfomycin—Dermatitis—Fluorouracil—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Fosfomycin—Pharyngitis—Doxorubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Fosfomycin—Decreased appetite—Docetaxel—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Fosfomycin—Headache—Fluorouracil—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Fosfomycin—Nausea—Irinotecan—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Fosfomycin—Constipation—Docetaxel—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Fosfomycin—Pain—Docetaxel—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Fosfomycin—Nausea—Gemcitabine—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Fosfomycin—Nausea—Fluorouracil—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Fosfomycin—Flatulence—Epirubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Fosfomycin—Tension—Epirubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Fosfomycin—Nervousness—Epirubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Fosfomycin—Back pain—Epirubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Fosfomycin—Abdominal pain—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Fosfomycin—Body temperature increased—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Fosfomycin—Flatulence—Doxorubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Fosfomycin—Tension—Doxorubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Fosfomycin—Nervousness—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Fosfomycin—Back pain—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Fosfomycin—Asthenia—Docetaxel—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Fosfomycin—Pruritus—Docetaxel—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Fosfomycin—Myalgia—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Fosfomycin—Dry mouth—Epirubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Fosfomycin—Diarrhoea—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Fosfomycin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Fosfomycin—Infection—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Fosfomycin—Dizziness—Docetaxel—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Fosfomycin—Skin disorder—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Fosfomycin—Myalgia—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Fosfomycin—Anorexia—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Fosfomycin—Dry mouth—Doxorubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Fosfomycin—Vomiting—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Fosfomycin—Rash—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Fosfomycin—Dermatitis—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Fosfomycin—Headache—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Fosfomycin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Fosfomycin—Infection—Doxorubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Fosfomycin—Insomnia—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Fosfomycin—Skin disorder—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Fosfomycin—Paraesthesia—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Fosfomycin—Somnolence—Epirubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Fosfomycin—Anorexia—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Fosfomycin—Nausea—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Fosfomycin—Dyspepsia—Epirubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Fosfomycin—Decreased appetite—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Fosfomycin—Pain—Epirubicin—pancreatic cancer	0.00099	0.00099	CcSEcCtD
Fosfomycin—Constipation—Epirubicin—pancreatic cancer	0.00099	0.00099	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000976	0.000976	CcSEcCtD
Fosfomycin—Insomnia—Doxorubicin—pancreatic cancer	0.000969	0.000969	CcSEcCtD
Fosfomycin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000962	0.000962	CcSEcCtD
Fosfomycin—Somnolence—Doxorubicin—pancreatic cancer	0.000952	0.000952	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000947	0.000947	CcSEcCtD
Fosfomycin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000943	0.000943	CcSEcCtD
Fosfomycin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000931	0.000931	CcSEcCtD
Fosfomycin—Constipation—Doxorubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Fosfomycin—Pain—Doxorubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Fosfomycin—Abdominal pain—Epirubicin—pancreatic cancer	0.000915	0.000915	CcSEcCtD
Fosfomycin—Body temperature increased—Epirubicin—pancreatic cancer	0.000915	0.000915	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Fosfomycin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000847	0.000847	CcSEcCtD
Fosfomycin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000847	0.000847	CcSEcCtD
Fosfomycin—Asthenia—Epirubicin—pancreatic cancer	0.000831	0.000831	CcSEcCtD
Fosfomycin—Pruritus—Epirubicin—pancreatic cancer	0.000819	0.000819	CcSEcCtD
Fosfomycin—Diarrhoea—Epirubicin—pancreatic cancer	0.000792	0.000792	CcSEcCtD
Fosfomycin—Asthenia—Doxorubicin—pancreatic cancer	0.000769	0.000769	CcSEcCtD
Fosfomycin—Dizziness—Epirubicin—pancreatic cancer	0.000766	0.000766	CcSEcCtD
Fosfomycin—Pruritus—Doxorubicin—pancreatic cancer	0.000758	0.000758	CcSEcCtD
Fosfomycin—Vomiting—Epirubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Fosfomycin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000733	0.000733	CcSEcCtD
Fosfomycin—Rash—Epirubicin—pancreatic cancer	0.00073	0.00073	CcSEcCtD
Fosfomycin—Dermatitis—Epirubicin—pancreatic cancer	0.000729	0.000729	CcSEcCtD
Fosfomycin—Headache—Epirubicin—pancreatic cancer	0.000725	0.000725	CcSEcCtD
Fosfomycin—Dizziness—Doxorubicin—pancreatic cancer	0.000708	0.000708	CcSEcCtD
Fosfomycin—Nausea—Epirubicin—pancreatic cancer	0.000688	0.000688	CcSEcCtD
Fosfomycin—Vomiting—Doxorubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Fosfomycin—Rash—Doxorubicin—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Fosfomycin—Dermatitis—Doxorubicin—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Fosfomycin—Headache—Doxorubicin—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Fosfomycin—Nausea—Doxorubicin—pancreatic cancer	0.000636	0.000636	CcSEcCtD
